![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2023
Simpson, Eric L.; Pink, Andrew E.; Blauvelt, Andrew; Gooderham, Melinda; Armstrong, April W.; Worm, Margitta; Katoh, Norito; Peris, Ketty; Puig, Luis; Barbarot, Sébastien; Mark, Thomas; Steffensen, Louise Abildgaard; Tindberg, Ann-Marie und Wollenberg, Andreas 
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
ORCID: https://orcid.org/0000-0003-0177-8722
(2023):
Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials.
In: American Journal of Clinical Dermatology, Bd. 24, Nr. 6: S. 939-952
[PDF, 2MB]
2022
Simpson, Eric L.; Wollenberg, Andreas; Soong, Weily; Steffensen, Louise Abildgaard; Kurbasic, Azra; Schneider, Shannon; Zoidis, John und Silverberg, Jonathan I.
(2022):
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3).
In: Annals of Allergy Asthma & Immunology, Bd. 129, Nr. 5: S. 592-604